Loading organizations...
§ Private Profile · Nanjing, Jiangsu, China
pharmatech company providing intermediates and CMO services for pharmaceutical development and production.
Nanjing F&S Pharmatech Co., Ltd. is a specialized pharmaceutical technology company based in Nanjing, China, that focuses on comprehensive drug development, chemical intermediates, and contract manufacturing organization services. The enterprise operates within the broader life sciences sector by supplying essential chemical materials and outsourced production capabilities to other commercial drug developers, though specific customer identities remain undisclosed. While specific revenue figures, valuation metrics, and employee counts are not publicly available, the business has successfully completed five distinct rounds of financing to support its ongoing operational growth. The F&S Pharmatech business was originally established in October 2015 by an undisclosed group of founding members to serve institutional clients within the global pharmaceutical industry. Recent corporate registry records indicate that the company's active operational status has been officially archived, marking the latest known development for the commercial firm.
F&S Pharmatech has raised $7.3M across 1 funding round.
F&S Pharmatech has raised $7.3M in total across 1 funding round.
F&S Pharmatech has raised $7.3M in total across 1 funding round.
F&S Pharmatech's investors include Kaitai Capital.
F&S Pharmatech has raised $7.3M across 1 funding round. Most recently, it raised $7.3M Series A in September 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 30, 2018 | $7.3M Series A | Kaitai Capital | — | Announced |